Prostate Cancer

The goal of cancer immunotherapy is to improve the body’s natural ability to find and destroy cancer cells. Successful immunotherapeutic approaches stimulate the natural defenses of the immune system and provide new ways to attack cancer. This is possible with comprehensive interventions that include cell therapy / immuno-pharmacological therapy in combination with nutritional, endocrine measures and supplements.

Cancer vaccines deliver a cancer-specific protein to the body and direct the immune system to target cells that contain that protein. A vaccine developed for prostate cancer called was designed to trigger the immune system to attack cells that have PSA on their surface.

Chimeric antigen receptor (CAR)-modified T-cell immunotherapy involves taking the patient’s T cells, genetically engineering the T cells to produce receptors that direct them to the cancer cells, and returning these CAR T cells to the patient’s body (NCI 2017b).

T-cell Modulators are peptide chains composed of tens of amino acids that appear to store all the experience of the immune system. The great intellectual leap to understand is that T-cell Modulators do not transfer antibodies nor create them directly, but its function is to educate, and teach the immune cells to recognize specific antigens that could happen to them unnoticed i.e. Prostate malignant cells.

T-cell Modulators do not cure anything but work to make a “smarter” immune system so that it

is the body itself eliminating disease. They are therefore vital in developing the strategies of the immune system against cancer.

T-cell Modulators contains several immunoactive components that have been shown to act synergistically in raising Dendritic and NK function and also effective as adjuvant therapy in Prostate cancer treatments, elevating dendritic and NK function as much as 250%

Hyperthermia involves the use of heat to directly treat a tumor or increase the vulnerability of cancer cells to other forms of treatment, such as immunotherapy, vitamin C, chemotherapy or radiotherapy.

Concerning clinical trials, hyperthermia has already shown antitumor activity and has a potential role in the treatment of prostate cancer.

Non-ablative or mild hyperthermia (HT) has been shown in preclinical and clinical studies as a localized sensitizer that enhances the tumoricidal effects of immunotherapy, radiation or chemotherapy.

A novel, minimally invasive interventional technique, HT has been suggested to improve the efficacy of chemotherapy for solid organ tumors.

Thus, hyperthermia may be a promising approach in prostate cancer treatment that enhances the cytotoxic effect of the chosen therapeutics.

Mistletoe helps fight tumor-induced immune suppression. Natural killer cells (NK) are a type of white blood cell that looks for and destroys Prostate cancer cells. Research has shown that NK cells can spontaneously recognize and kill a variety of Prostate cancer cells.

Mistletoe has been called a “biological response modifier” due to its ability to improve various aspects of immune function. Studies show that it activates natural killer cells, T cells, macrophages and monocytes.

A special proprietary form of liposomal mistletoe created with nanotechnology has been created for use in our Prostate cancer treatment approach.

Glutathione is the most important antioxidant produced by your body and a master detoxifier of every cell in your body. It prevents cellular damage caused by free radicals and peroxides.

Glutathione metabolism is able to play both protective and pathogenic roles. It is crucial in the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. However, by conferring resistance to a number of chemotherapeutic drugs, elevated levels of glutathione in tumor cells are able to protect such cells

A typical diet, characterized by dependence on animal products, refined carbohydrates and unhealthy fats such as processed vegetable oils, can promote an inflammatory environment in the body. A pro-inflammatory diet has been associated with an increased risk of Prostate cancer and an increased risk of death from Prostate cancer.

We custom-make a diet targeted to enhance the immune system’s ability to heal and provide our patients with the right nutrition for their current and long-term needs.

Patients with higher vitamin D levels were significantly less likely to die from the disease (Mondul 2016). In another study, short-term supplementation with high-dose vitamin D for three to eight weeks lowered PSA levels (Wagner 2013).

Hormone Therapy
Hormone therapy can weaken the bones of prostate cancer patients, but supplemental vitamin D may help prevent fractures in these patients (Ottanelli 2015; Dueregger 2014).

A study examining factors associated with bone preservation in prostate cancer patients using hormone therapies found that those taking vitamin D supplements experienced less bone loss in their lower-back vertebrae (Alibhai 2013).

Healthy prostate cells accumulate zinc to accomplish their normal cellular functions. In contrast, prostate cancer cells have depleted zinc stores, which makes them less susceptible to cell death.

Melatonin, a hormone best known for its role in regulating sleep, is also emerging as a promising anti-cancer agent. Evidence to date has shown that melatonin can interfere with cancer initiation, progression, and metastasis.

These fatty acids have many health benefits and may even slow the growth of prostate cancer. In laboratory and animal studies, omega-3 fatty acids were found to inhibit inflammation, interfere with blood vessel growth in tumors, and cause cancer cells to die.

In a study that included more than 290,000 men, those who reported high fish and high omega-3 fatty acid intake on diet questionnaires at the beginning of the study were significantly less likely to die from prostate cancer during approximately 20 years of follow up

Curcumin, a carotenoid pigment extracted from the spice turmeric, has well-established anti-inflammatory and oxidative stress-reducing effects. In laboratory studies, curcumin interfered with cancer growth signals, decreased androgen receptor activity, reduced production of PSA, and slowed tumor growth